glp 1 stomach issues GLP-1 GLP-1 Causing Nausea: Navigating Side
Description
The overall trend is what matters most
September 2025: Pfizer announced its agreement to acquire Metsera in a deal valued at up to USD 7.3 billion, strengthening its pipeline of next-generation GLP-1, amylin, and obesity therapies
Difficulty finding words mid-sentence, trouble concentrating during meetings, feeling mentally foggy
Adults with diabetes
Small molecule allosteric modulation of the glucagon-like peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin
But the indication for the drug isn't BMI of 30 and has tried a bunch of other stuff
